1. Home
  2. RYAM vs BIOA Comparison

RYAM vs BIOA Comparison

Compare RYAM & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

HOLD

Current Price

$5.84

Market Cap

422.1M

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$14.08

Market Cap

443.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAM
BIOA
Founded
1926
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.1M
443.9M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
RYAM
BIOA
Price
$5.84
$14.08
Analyst Decision
Buy
Buy
Analyst Count
1
3
Target Price
$6.00
$13.50
AVG Volume (30 Days)
544.0K
474.9K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,471,356,000.00
$5,917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.35
$2.88
52 Week High
$8.56
$14.46

Technical Indicators

Market Signals
Indicator
RYAM
BIOA
Relative Strength Index (RSI) 41.16 77.95
Support Level $5.59 $12.93
Resistance Level $5.92 $13.68
Average True Range (ATR) 0.22 0.83
MACD -0.02 0.07
Stochastic Oscillator 27.93 91.01

Price Performance

Historical Comparison
RYAM
BIOA

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: